Approval · Notice of Compliance 32022 · 2023
PERSANTINE: Notice of Compliance 32022
Issued November 1, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32022
- Date
- November 1, 2023
- Company
- Glenwood Gmbh Pharmazeutische ErzeugnisseMunich, --, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site. Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERSANTINE | Not yet assigned | — |
Medicinal ingredients
- DIPYRIDAMOLE 5 MG per ML